TPD & Induced Proximity Summit Leaderboard
  • Sunday, July 5, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 328

Author

Pharma Journalist 8916 posts 0 comments

Eton Pharmaceuticals and Azurity Pharmaceuticals, Inc. Announce FDA Approval of EPRONTIA…

Nov 9, 2021
Eton Pharmaceuticals, Inc and Azurity Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved EPRONTIA (topiramate) oral solution, 25mg/mL.…
Read More...

FDA Grants Profounda Orphan Drug Designation Approval for treatment of Treatment of Invasive…

Nov 9, 2021
Profounda, Inc. ("Profounda") announced that it has received the US Food and Drug Administration's Orphan Drug Designation Approval for the use of miltefosine to treat Invasive…
Read More...

Merck Announces Receipt of Antitrust Clearance in Germany and Austria Relating to Tender Offer to…

Nov 8, 2021
Merck known as MSD outside the United States and Canada, today announced that its pending acquisition of Acceleron Pharma Inc. (Nasdaq: XLRN) has been cleared by the competition…
Read More...

Azurity Pharmaceuticals Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution

Nov 8, 2021
Azurity Pharmaceuticals, Inc. a private specialty pharmaceutical company focused on developing innovative products to meet the unique needs of patients with underserved conditions,…
Read More...

EffRx Obtains Swiss Marketing Authorization for Bronchitol in Cystic Fibrosis

Nov 8, 2021
EffRx Pharmaceuticals SA, a commercial-stage company that commercializes niche and orphan medicines in Switzerland and Europe, today announced that Swissmedic has approved Bronchitol…
Read More...

Ocugen Announces Submission of Emergency Use Authorization Request to the US FDA for Investigational…

Nov 8, 2021
Ocugen, Inc. a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics and vaccines, announced today that it has submitted a request to the…
Read More...

Green Circle Life Launches Covid-19 Vaccination Mandate Compliance Solution

Nov 4, 2021
Green Circle Life, provider of an all-in-one communication and engagement platform SmartFHR, has launched the Covid Passport, their end-to-end solution to help employers comply with an…
Read More...

Acticor Biotech Announces FDA Acceptance of IND Application for glenzocimab in Acute Ischemic Stroke

Nov 4, 2021
ACTICOR BIOTECH, a clinical stage biotechnology company involved in the acute phase of thrombotic diseases, announces that the U.S Food and Drug Administration (FDA) has provided…
Read More...

FDA Declines Emergency Use Authorization for ZYESAMI (aviptadil) for Patients with Critical COVID-19…

Nov 4, 2021
NRx Pharmaceuticals a clinical-stage biopharmaceutical company (NRx), today announced that the US Food and Drug Administration (FDA) has declined to issue an Emergency Use Authorization…
Read More...

Yokogawa Acquires Insilico Biotechnology, Developer of Innovative Bioprocess Digital Twin Technology

Nov 2, 2021
Yokogawa Electric Corporation  announces that it has acquired all shares of Insilico Biotechnology AG (“Insilico”), a Stuttgart, Germany-based developer and provider of bioprocess…
Read More...
Prev Next
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy
  • Lonza Secures Nona’s BBB Technology for CNS Drug Development
  • Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment
  • AlzeCure Licenses Alzheimer’s Drug Candidate ACD856 in $2.2B Deal
  • Inocras, AimedBio Partner to Advance ADC Precision Oncology Development

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.